OTC Pharmaceuticals Global Industry Almanac 2016
- Pages: 491
- Published: October 2016
- Report Code: MLIG16046-01
Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Scope
Essential resource for top-line data and analysis covering the global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.
Reasons to buy
- What was the size of the global otc pharmaceuticals market by value in 2015?- What will be the size of the global otc pharmaceuticals market in 2020?
- What factors are affecting the strength of competition in the global otc pharmaceuticals market?
- H
Companies mentioned
None
Table of Contents
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global OTC Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Indonesia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in North America
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Scandinavia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Singapore
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in South Korea
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Turkey
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine
List of Tables
Table 1: Global OTC pharmaceuticals market value: $ million, 201115
Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Global OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Global OTC pharmaceuticals market value forecast: $ million, 201520
Table 7: Asia-Pacific OTC pharmaceuticals market value: $ million, 201115
Table 8: AsiaPacific OTC pharmaceuticals market category segmentation: $ million, 2015
Table 9: AsiaPacific OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 10: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Table 11: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Table 12: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 201520
Table 13: Europe OTC pharmaceuticals market value: $ million, 201115
Table 14: Europe OTC pharmaceuticals market category segmentation: $ million, 2015
Table 15: Europe OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 16: Europe OTC pharmaceuticals market share: % share, by value, 2015
Table 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
Table 18: Europe OTC pharmaceuticals market value forecast: $ million, 201520
Table 19: France OTC pharmaceuticals market value: $ million, 201115
Table 20: France OTC pharmaceuticals market category segmentation: $ million, 2015
Table 21: France OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 22: France OTC pharmaceuticals market share: % share, by value, 2015
Table 23: France OTC pharmaceuticals market distribution: % share, by value, 2015
Table 24: France OTC pharmaceuticals market value forecast: $ million, 201520
Table 25: France size of population (million), 201115
Table 26: France gdp (constant 2005 prices, $ billion), 201115
Table 27: France gdp (current prices, $ billion), 201115
Table 28: France inflation, 201115
Table 29: France consumer price index (absolute), 201115
Table 30: France exchange rate, 201115
Table 31: Germany OTC pharmaceuticals market value: $ million, 201115
Table 32: Germany OTC pharmaceuticals market category segmentation: $ million, 2015
Table 33: Germany OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 34: Germany OTC pharmaceuticals market share: % share, by value, 2015
Table 35: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
Table 36: Germany OTC pharmaceuticals market value forecast: $ million, 201520
Table 37: Germany size of population (million), 201115
Table 38: Germany gdp (constant 2005 prices, $ billion), 201115
Table 39: Germany gdp (current prices, $ billion), 201115
Table 40: Germany inflation, 201115
Table 41: Germany consumer price index (absolute), 201115
Table 42: Germany exchange rate, 201115
Table 43: Australia OTC pharmaceuticals market value: $ million, 201115
Table 44: Australia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 45: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 46: Australia OTC pharmaceuticals market share: % share, by value, 2015
Table 47: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 48: Australia OTC pharmaceuticals market value forecast: $ million, 201520
Table 49: Australia size of population (million), 201115
Table 50: Australia gdp (constant 2005 prices, $ billion), 201115
Table 51: Australia gdp (current prices, $ billion), 201115
Table 52: Australia inflation, 201115
Table 53: Australia consumer price index (absolute), 201115
Table 54: Australia exchange rate, 201115
Table 55: Brazil OTC pharmaceuticals market value: $ million, 201115
Table 56: Brazil OTC pharmaceuticals market category segmentation: $ million, 2015
Table 57: Brazil OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 58: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Table 59: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Table 60: Brazil OTC pharmaceuticals market value forecast: $ million, 201520
Table 61: Brazil size of population (million), 201115
Table 62: Brazil gdp (constant 2005 prices, $ billion), 201115
Table 63: Brazil gdp (current prices, $ billion), 201115
Table 64: Brazil inflation, 201115
Table 65: Brazil consumer price index (absolute), 201115
Table 66: Brazil exchange rate, 201115
Table 67: Canada OTC pharmaceuticals market value: $ million, 201115
Table 68: Canada OTC pharmaceuticals market category segmentation: $ million, 2015
Table 69: Canada OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 70: Canada OTC pharmaceuticals market share: % share, by value, 2015
Table 71: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Table 72: Canada OTC pharmaceuticals market value forecast: $ million, 201520
Table 73: Canada size of population (million), 201115
Table 74: Canada gdp (constant 2005 prices, $ billion), 201115
Table 75: Canada gdp (current prices, $ billion), 201115
Table 76: Canada inflation, 201115
Table 77: Canada consumer price index (absolute), 201115
Table 78: Canada exchange rate, 201115
Table 79: China OTC pharmaceuticals market value: $ million, 201115
Table 80: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 81: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 82: China OTC pharmaceuticals market share: % share, by value, 2015
Table 83: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 84: China OTC pharmaceuticals market value forecast: $ million, 201520
Table 85: China size of population (million), 201115
Table 86: China gdp (constant 2005 prices, $ billion), 201115
Table 87: China gdp (current prices, $ billion), 201115
Table 88: China inflation, 201115
Table 89: China consumer price index (absolute), 201115
Table 90: China exchange rate, 201115
Table 91: India OTC pharmaceuticals market value: $ million, 201115
Table 92: India OTC pharmaceuticals market category segmentation: $ million, 2015
Table 93: India OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 94: India OTC pharmaceuticals market share: % share, by value, 2015
Table 95: India OTC pharmaceuticals market distribution: % share, by value, 2015
Table 96: India OTC pharmaceuticals market value forecast: $ million, 201520
Table 97: India size of population (million), 201115
Table 98: India gdp (constant 2005 prices, $ billion), 201115
Table 99: India gdp (current prices, $ billion), 201115
Table 100: India inflation, 201115
Table 101: India consumer price index (absolute), 201115
Table 102: India exchange rate, 201115
Table 103: Indonesia OTC pharmaceuticals market value: $ million, 201115
Table 104: Indonesia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 105: Indonesia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 106: Indonesia OTC pharmaceuticals market share: % share, by value, 2015
Table 107: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 108: Indonesia OTC pharmaceuticals market value forecast: $ million, 201520
Table 109: Indonesia size of population (million), 201115
Table 110: Indonesia gdp (constant 2005 prices, $ billion), 201115
Table 111: Indonesia gdp (current prices, $ billion), 201115
Table 112: Indonesia inflation, 201115
Table 113: Indonesia consumer price index (absolute), 201115
Table 114: Indonesia exchange rate, 201115
Table 115: Italy OTC pharmaceuticals market value: $ million, 201115
Table 116: Italy OTC pharmaceuticals market category segmentation: $ million, 2015
Table 117: Italy OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 118: Italy OTC pharmaceuticals market share: % share, by value, 2015
Table 119: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Table 120: Italy OTC pharmaceuticals market value forecast: $ million, 201520
Table 121: Italy size of population (million), 201115
Table 122: Italy gdp (constant 2005 prices, $ billion), 201115
Table 123: Italy gdp (current prices, $ billion), 201115
Table 124: Italy inflation, 201115
Table 125: Italy consumer price index (absolute), 201115
Table 126: Italy exchange rate, 201115
Table 127: Japan OTC pharmaceuticals market value: $ million, 201115
Table 128: Japan OTC pharmaceuticals market category segmentation: $ million, 2015
Table 129: Japan OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 130: Japan OTC pharmaceuticals market share: % share, by value, 2015
Table 131: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Table 132: Japan OTC pharmaceuticals market value forecast: $ million, 201520
Table 133: Japan size of population (million), 201115
Table 134: Japan gdp (constant 2005 prices, $ billion), 201115
Table 135: Japan gdp (current prices, $ billion), 201115
Table 136: Japan inflation, 201115
Table 137: Japan consumer price index (absolute), 201115
Table 138: Japan exchange rate, 201115
Table 139: Mexico OTC pharmaceuticals market value: $ million, 201115
Table 140: Mexico OTC pharmaceuticals market category segmentation: $ million, 2015
Table 141: Mexico OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 142: Mexico OTC pharmaceuticals market share: % share, by value, 2015
Table 143: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015
Table 144: Mexico OTC pharmaceuticals market value forecast: $ million, 201520
Table 145: Mexico size of population (million), 201115
Table 146: Mexico gdp (constant 2005 prices, $ billion), 201115
Table 147: Mexico gdp (current prices, $ billion), 201115
Table 148: Mexico inflation, 201115
Table 149: Mexico consumer price index (absolute), 201115
Table 150: Mexico exchange rate, 201115
Table 151: Netherlands OTC pharmaceuticals market value: $ million, 201115
Table 152: Netherlands OTC pharmaceuticals market category segmentation: $ million, 2015
Table 153: Netherlands OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 154: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
Table 155: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
Table 156: Netherlands OTC pharmaceuticals market value forecast: $ million, 201520
Table 157: Netherlands size of population (million), 201115
Table 158: Netherlands gdp (constant 2005 prices, $ billion), 201115
Table 159: Netherlands gdp (current prices, $ billion), 201115
Table 160: Netherlands inflation, 201115
Table 161: Netherlands consumer price index (absolute), 201115
Table 162: Netherlands exchange rate, 201115
Table 163: North America OTC pharmaceuticals market value: $ million, 201115
Table 164: North America OTC pharmaceuticals market category segmentation: $ million, 2015
Table 165: North America OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 166: North America OTC pharmaceuticals market share: % share, by value, 2015
Table 167: North America OTC pharmaceuticals market distribution: % share, by value, 2015
Table 168: North America OTC pharmaceuticals market value forecast: $ million, 201520
Table 169: Russia OTC pharmaceuticals market value: $ million, 201115
Table 170: Russia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 171: Russia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 172: Russia OTC pharmaceuticals market share: % share, by value, 2015
Table 173: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 174: Russia OTC pharmaceuticals market value forecast: $ million, 201520
Table 175: Russia size of population (million), 201115
Table 176: Russia gdp (constant 2005 prices, $ billion), 201115
Table 177: Russia gdp (current prices, $ billion), 201115
Table 178: Russia inflation, 201115
Table 179: Russia consumer price index (absolute), 201115
Table 180: Russia exchange rate, 201115
Table 181: Scandinavia OTC pharmaceuticals market value: $ million, 201115
Table 182: Scandinavia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 183: Scandinavia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 184: Scandinavia OTC pharmaceuticals market share: % share, by value, 2015
Table 185: Scandinavia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 186: Scandinavia OTC pharmaceuticals market value forecast: $ million, 201520
Table 187: Singapore OTC pharmaceuticals market value: $ million, 201115
Table 188: Singapore OTC pharmaceuticals market category segmentation: $ million, 2015
Table 189: Singapore OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 190: Singapore OTC pharmaceuticals market share: % share, by value, 2015
Table 191: Singapore OTC pharmaceuticals market distribution: % share, by value, 2015
Table 192: Singapore OTC pharmaceuticals market value forecast: $ million, 201520
Table 193: Singapore size of population (million), 201115
Table 194: Singapore gdp (constant 2005 prices, $ billion), 201115
Table 195: Singapore gdp (current prices, $ billion), 201115
Table 196: Singapore inflation, 201115
Table 197: Singapore consumer price index (absolute), 201115
Table 198: Singapore exchange rate, 201115
Table 199: South Africa OTC pharmaceuticals market value: $ million, 201115
Table 200: South Africa OTC pharmaceuticals market category segmentation: $ million, 2015
Table 201: South Africa OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 202: South Africa OTC pharmaceuticals market share: % share, by value, 2015
Table 203: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015
Table 204: South Africa OTC pharmaceuticals market value forecast: $ million, 201520
Table 205: South Africa size of population (million), 201115
Table 206: South Africa gdp (constant 2005 prices, $ billion), 201115
Table 207: South Africa gdp (current prices, $ billion), 201115
Table 208: South Africa inflation, 201115
Table 209: South Africa consumer price index (absolute), 201115
Table 210: South Africa exchange rate, 201115
Table 211: South Korea OTC pharmaceuticals market value: $ million, 201115
Table 212: South Korea OTC pharmaceuticals market category segmentation: $ million, 2015
Table 213: South Korea OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 214: South Korea OTC pharmaceuticals market share: % share, by value, 2015
Table 215: South Korea OTC pharmaceuticals market distribution: % share, by value, 2015
Table 216: South Korea OTC pharmaceuticals market value forecast: $ million, 201520
Table 217: South Korea size of population (million), 201115
Table 218: South Korea gdp (constant 2005 prices, $ billion), 201115
Table 219: South Korea gdp (current prices, $ billion), 201115
Table 220: South Korea inflation, 201115
Table 221: South Korea consumer price index (absolute), 201115
Table 222: South Korea exchange rate, 201115
Table 223: Spain OTC pharmaceuticals market value: $ million, 201115
Table 224: Spain OTC pharmaceuticals market category segmentation: $ million, 2015
Table 225: Spain OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 226: Spain OTC pharmaceuticals market share: % share, by value, 2015
Table 227: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
Table 228: Spain OTC pharmaceuticals market value forecast: $ million, 201520
Table 229: Spain size of population (million), 201115
Table 230: Spain gdp (constant 2005 prices, $ billion), 201115
Table 231: Spain gdp (current prices, $ billion), 201115
Table 232: Spain inflation, 201115
Table 233: Spain consumer price index (absolute), 201115
Table 234: Spain exchange rate, 201115
Table 235: Turkey OTC pharmaceuticals market value: $ million, 201115
Table 236: Turkey OTC pharmaceuticals market category segmentation: $ million, 2015
Table 237: Turkey OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 238: Turkey OTC pharmaceuticals market share: % share, by value, 2015
Table 239: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015
Table 240: Turkey OTC pharmaceuticals market value forecast: $ million, 201520
Table 241: Turkey size of population (million), 201115
Table 242: Turkey gdp (constant 2005 prices, $ billion), 201115
Table 243: Turkey gdp (current prices, $ billion), 201115
Table 244: Turkey inflation, 201115
Table 245: Turkey consumer price index (absolute), 201115
Table 246: Turkey exchange rate, 201115
Table 247: United Kingdom OTC pharmaceuticals market value: $ million, 201115
Table 248: United Kingdom OTC pharmaceuticals market category segmentation: $ million, 2015
Table 249: United Kingdom OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 250: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
Table 251: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
Table 252: United Kingdom OTC pharmaceuticals market value forecast: $ million, 201520
Table 253: United Kingdom size of population (million), 201115
Table 254: United Kingdom gdp (constant 2005 prices, $ billion), 201115
Table 255: United Kingdom gdp (current prices, $ billion), 201115
Table 256: United Kingdom inflation, 201115
Table 257: United Kingdom consumer price index (absolute), 201115
Table 258: United Kingdom exchange rate, 201115
Table 259: United States OTC pharmaceuticals market value: $ million, 201115
Table 260: United States OTC pharmaceuticals market category segmentation: $ million, 2015
Table 261: United States OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 262: United States OTC pharmaceuticals market share: % share, by value, 2015
Table 263: United States OTC pharmaceuticals market distribution: % share, by value, 2015
Table 264: United States OTC pharmaceuticals market value forecast: $ million, 201520
Table 265: United States size of population (million), 201115
Table 266: United States gdp (constant 2005 prices, $ billion), 201115
Table 267: United States gdp (current prices, $ billion), 201115
Table 268: United States inflation, 201115
Table 269: United States consumer price index (absolute), 201115
Table 270: United States exchange rate, 201115
Table 271: Bayer AG: key facts
Table 272: Bayer AG: key financials ($)
Table 273: Bayer AG: key financials (€)
Table 274: Bayer AG: key financial ratios
Table 275: GlaxoSmithKline Plc: key facts
Table 276: GlaxoSmithKline Plc: key financials ($)
Table 277: GlaxoSmithKline Plc: key financials (£)
Table 278: GlaxoSmithKline Plc: key financial ratios
Table 279: Johnson & Johnson: key facts
Table 280: Johnson & Johnson: key financials ($)
Table 281: Johnson & Johnson: key financial ratios
Table 282: Novartis AG: key facts
Table 283: Novartis AG: key financials ($)
Table 284: Novartis AG: key financial ratios
Table 285: Nin Jiom Medicines Manufactory Ltd: key facts
Table 286: The Procter & Gamble Company: key facts
Table 287: The Procter & Gamble Company: key financials ($)
Table 288: The Procter & Gamble Company: key financial ratios
Table 289: Reckitt Benckiser Group plc: key facts
Table 290: Reckitt Benckiser Group plc: key financials ($)
Table 291: Reckitt Benckiser Group plc: key financials (£)
Table 292: Reckitt Benckiser Group plc: key financial ratios
Table 293: Sanofi SA: key facts
Table 294: Sanofi SA: key financials ($)
Table 295: Sanofi SA: key financials (€)
Table 296: Sanofi SA: key financial ratios
Table 297: Almirall S.A.: key facts
Table 298: Almirall S.A.: key financials ($)
Table 299: Almirall S.A.: key financials (€)
Table 300: Almirall S.A.: key financial ratios
Table 301: Pfizer Inc.: key facts
Table 302: Pfizer Inc.: key financials ($)
Table 303: Pfizer Inc.: key financial ratios
Table 304: Suntory Group: key facts
Table 305: Suntory Group: key financials ($)
Table 306: Suntory Group: key financials (Â¥)
Table 307: Suntory Group: key financial ratios
Table 308: Abbott Laboratories: key facts
Table 309: Abbott Laboratories: key financials ($)
Table 310: Abbott Laboratories: key financial ratios
Table 311: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts
Table 312: Cipla Limited: key facts
Table 313: Cipla Limited: key financials ($)
Table 314: Cipla Limited: key financials (Rs.)
Table 315: Cipla Limited: key financial ratios
Table 316: Dabur India Limited: key facts
Table 317: Dabur India Limited: key financials ($)
Table 318: Dabur India Limited: key financials (Rs.)
Table 319: Dabur India Limited: key financial ratios
Table 320: Darya-Varia Laboratoria Tbk: key facts
Table 321: Darya-Varia Laboratoria Tbk: key financials ($)
Table 322: Darya-Varia Laboratoria Tbk: key financials (IDR)
Table 323: Darya-Varia Laboratoria Tbk: key financial ratios
Table 324: PT Kalbe Farma Tbk: key facts
Table 325: PT Kalbe Farma Tbk: key financials ($)
Table 326: PT Kalbe Farma Tbk: key financials (IDR)
Table 327: PT Kalbe Farma Tbk: key financial ratios
Table 328: Boehringer Ingelheim GmbH: key facts
Table 329: Boehringer Ingelheim GmbH: key financials ($)
Table 330: Boehringer Ingelheim GmbH: key financials (€)
Table 331: Boehringer Ingelheim GmbH: key financial ratios
Table 332: Daiichi Sankyo Co., Ltd.: key facts
Table 333: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 334: Daiichi Sankyo Co., Ltd.: key financials (Â¥)
Table 335: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 336: Kracie Holdings, Ltd.: key facts
Table 337: Bristol Myers Squibb Company: key facts
Table 338: Bristol Myers Squibb Company: key financials ($)
Table 339: Bristol Myers Squibb Company: key financial ratios
Table 340: Royal DSM N.V.: key facts
Table 341: Royal DSM N.V.: key financials ($)
Table 342: Royal DSM N.V.: key financials (€)
Table 343: Royal DSM N.V.: key financial ratios
Table 344: JSC ELFA: key facts
Table 345: The Menarini Group: key facts
Table 346: The Menarini Group: key financials ($)
Table 347: The Menarini Group: key financials (€)
Table 348: The Menarini Group: key financial ratios
Table 349: Pharmstandard OJSC: key facts
Table 350: Pharmstandard OJSC: key financials ($)
Table 351: Pharmstandard OJSC: key financials (RUB)
Table 352: Pharmstandard OJSC: key financial ratios
Table 353: Eu Yan Sang International Ltd.: key facts
Table 354: Eu Yan Sang International Ltd.: key financials ($)
Table 355: Eu Yan Sang International Ltd.: key financials (Si$)
Table 356: Eu Yan Sang International Ltd.: key financial ratios
Table 357: Adcock Ingram Holdings Limited: key facts
Table 358: Adcock Ingram Holdings Limited: key financials ($)
Table 359: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 360: Adcock Ingram Holdings Limited: key financial ratios
Table 361: Pharma Natura (Pty) Ltd.: key facts
Table 362: Weleda AG: key facts
Table 363: Boryung Pharm Co., Ltd.: key facts
Table 364: Boryung Pharm Co., Ltd.: key financials ($)
Table 365: Boryung Pharm Co., Ltd.: key financials (KRW)
Table 366: Boryung Pharm Co., Ltd.: key financial ratios
Table 367: Dongwha Pharm Co., Ltd.: key facts
Table 368: Whanin Pharmaceutical Co., Ltd.: key facts
Table 369: Whanin Pharmaceutical Co., Ltd.: key financials ($)
Table 370: Whanin Pharmaceutical Co., Ltd.: key financials (KRW)
Table 371: Whanin Pharmaceutical Co., Ltd.: key financial ratios
Table 372: Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.: key facts
Table 373: Nobel Ilac San ve Tic A.S.: key facts
List of Figures
Figure 1: Global OTC pharmaceuticals market value: $ million, 201115
Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 201520
Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2015
Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2015
Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2015
Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2015
Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2015
Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2015
Figure 13: Asia-Pacific OTC pharmaceuticals market value: $ million, 201115
Figure 14: AsiaPacific OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 15: AsiaPacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 16: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 201520
Figure 19: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 20: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 21: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 22: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 23: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 24: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 25: Europe OTC pharmaceuticals market value: $ million, 201115
Figure 26: Europe OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 27: Europe OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 28: Europe OTC pharmaceuticals market share: % share, by value, 2015
Figure 29: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 30: Europe OTC pharmaceuticals market value forecast: $ million, 201520
Figure 31: Forces driving competition in the OTC pharmaceuticals market in Europe, 2015
Figure 32: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2015
Figure 33: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2015
Figure 34: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2015
Figure 35: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2015
Figure 36: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2015
Figure 37: France OTC pharmaceuticals market value: $ million, 201115
Figure 38: France OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 39: France OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 40: France OTC pharmaceuticals market share: % share, by value, 2015
Figure 41: France OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 42: France OTC pharmaceuticals market value forecast: $ million, 201520
Figure 43: Forces driving competition in the OTC pharmaceuticals market in France, 2015
Figure 44: Drivers of buyer power in the OTC pharmaceuticals market in France, 2015
Figure 45: Drivers of supplier power in the OTC pharmaceuticals market in France, 2015
Figure 46: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in France, 2015
Figure 47: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in France, 2015
Figure 48: Drivers of degree of rivalry in the OTC pharmaceuticals market in France, 2015
Figure 49: Germany OTC pharmaceuticals market value: $ million, 201115
Figure 50: Germany OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 51: Germany OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 52: Germany OTC pharmaceuticals market share: % share, by value, 2015
Figure 53: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 54: Germany OTC pharmaceuticals market value forecast: $ million, 201520
Figure 55: Forces driving competition in the OTC pharmaceuticals market in Germany, 2015
Figure 56: Drivers of buyer power in the OTC pharmaceuticals market in Germany, 2015
Figure 57: Drivers of supplier power in the OTC pharmaceuticals market in Germany, 2015
Figure 58: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Germany, 2015
Figure 59: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Germany, 2015
Figure 60: Drivers of degree of rivalry in the OTC pharmaceuticals market in Germany, 2015
Figure 61: Australia OTC pharmaceuticals market value: $ million, 201115
Figure 62: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 63: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 64: Australia OTC pharmaceuticals market share: % share, by value, 2015
Figure 65: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 66: Australia OTC pharmaceuticals market value forecast: $ million, 201520
Figure 67: Forces driving competition in the OTC pharmaceuticals market in Australia, 2015
Figure 68: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2015
Figure 69: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2015
Figure 70: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2015
Figure 71: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2015
Figure 72: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2015
Figure 73: Brazil OTC pharmaceuticals market value: $ million, 201115
Figure 74: Brazil OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 75: Brazil OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 76: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Figure 77: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 78: Brazil OTC pharmaceuticals market value forecast: $ million, 201520
Figure 79: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2015
Figure 80: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2015
Figure 81: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2015
Figure 82: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2015
Figure 83: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2015
Figure 84: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2015
Figure 85: Canada OTC pharmaceuticals market value: $ million, 201115
Figure 86: Canada OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 87: Canada OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 88: Canada OTC pharmaceuticals market share: % share, by value, 2015
Figure 89: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 90: Canada OTC pharmaceuticals market value forecast: $ million, 201520
Figure 91: Forces driving competition in the OTC pharmaceuticals market in Canada, 2015
Figure 92: Drivers of buyer power in the OTC pharmaceuticals market in Canada, 2015
Figure 93: Drivers of supplier power in the OTC pharmaceuticals market in Canada, 2015
Figure 94: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Canada, 2015
Figure 95: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Canada, 2015
Figure 96: Drivers of degree of rivalry in the OTC pharmaceuticals market in Canada, 2015
Figure 97: China OTC pharmaceuticals market value: $ million, 201115
Figure 98: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 99: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 100: China OTC pharmaceuticals market share: % share, by value, 2015
Figure 101: China OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 102: China OTC pharmaceuticals market value forecast: $ million, 201520
Figure 103: Forces driving competition in the OTC pharmaceuticals market in China, 2015
Figure 104: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
Figure 105: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
Figure 106: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
Figure 107: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
Figure 108: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
Figure 109: India OTC pharmaceuticals market value: $ million, 201115
Figure 110: India OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 111: India OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 112: India OTC pharmaceuticals market share: % share, by value, 2015
Figure 113: India OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 114: India OTC pharmaceuticals market value forecast: $ million, 201520
Figure 115: Forces driving competition in the OTC pharmaceuticals market in India, 2015
Figure 116: Drivers of buyer power in the OTC pharmaceuticals market in India, 2015
Figure 117: Drivers of supplier power in the OTC pharmaceuticals market in India, 2015
Figure 118: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2015
Figure 119: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2015
Figure 120: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2015
Figure 121: Indonesia OTC pharmaceuticals market value: $ million, 201115
Figure 122: Indonesia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 123: Indonesia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 124: Indonesia OTC pharmaceuticals market share: % share, by value, 2015
Figure 125: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 126: Indonesia OTC pharmaceuticals market value forecast: $ million, 201520
Figure 127: Forces driving competition in the OTC pharmaceuticals market in Indonesia, 2015
Figure 128: Drivers of buyer power in the OTC pharmaceuticals market in Indonesia, 2015
Figure 129: Drivers of supplier power in the OTC pharmaceuticals market in Indonesia, 2015
Figure 130: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Indonesia, 2015
Figure 131: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Indonesia, 2015
Figure 132: Drivers of degree of rivalry in the OTC pharmaceuticals market in Indonesia, 2015
Figure 133: Italy OTC pharmaceuticals market value: $ million, 201115
Figure 134: Italy OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 135: Italy OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 136: Italy OTC pharmaceuticals market share: % share, by value, 2015
Figure 137: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 138: Italy OTC pharmaceuticals market value forecast: $ million, 201520
Figure 139: Forces driving competition in the OTC pharmaceuticals market in Italy, 2015
Figure 140: Drivers of buyer power in the OTC pharmaceuticals market in Italy, 2015
Figure 141: Drivers of supplier power in the OTC pharmaceuticals market in Italy, 2015
Figure 142: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Italy, 2015
Figure 143: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Italy, 2015
Figure 144: Drivers of degree of rivalry in the OTC pharmaceuticals market in Italy, 2015
Figure 145: Japan OTC pharmaceuticals market value: $ million, 201115
Figure 146: Japan OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 147: Japan OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 148: Japan OTC pharmaceuticals market share: % share, by value, 2015
Figure 149: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 150: Japan OTC pharmaceuticals market value forecast: $ million, 201520
Figure 151: Forces driving competition in the OTC pharmaceuticals market in Japan, 2015
Figure 152: Drivers of buyer power in the OTC pharmaceuticals market in Japan, 2015
Figure 153: Drivers of supplier power in the OTC pharmaceuticals market in Japan, 2015
Figure 154: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Japan, 2015
Figure 155: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Japan, 2015
Figure 156: Drivers of degree of rivalry in the OTC pharmaceuticals market in Japan, 2015
Figure 157: Mexico OTC pharmaceuticals market value: $ million, 201115
Figure 158: Mexico OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 159: Mexico OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 160: Mexico OTC pharmaceuticals market share: % share, by value, 2015
Figure 161: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 162: Mexico OTC pharmaceuticals market value forecast: $ million, 201520
Figure 163: Forces driving competition in the OTC pharmaceuticals market in Mexico, 2015
Figure 164: Drivers of buyer power in the OTC pharmaceuticals market in Mexico, 2015
Figure 165: Drivers of supplier power in the OTC pharmaceuticals market in Mexico, 2015
Figure 166: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Mexico, 2015
Figure 167: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Mexico, 2015
Figure 168: Drivers of degree of rivalry in the OTC pharmaceuticals market in Mexico, 2015
Figure 169: Netherlands OTC pharmaceuticals market value: $ million, 201115
Figure 170: Netherlands OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 171: Netherlands OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 172: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
Figure 173: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 174: Netherlands OTC pharmaceuticals market value forecast: $ million, 201520
Figure 175: Forces driving competition in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 176: Drivers of buyer power in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 177: Drivers of supplier power in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 178: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 179: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 180: Drivers of degree of rivalry in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 181: North America OTC pharmaceuticals market value: $ million, 201115
Figure 182: North America OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 183: North America OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 184: North America OTC pharmaceuticals market share: % share, by value, 2015
Figure 185: North America OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 186: North America OTC pharmaceuticals market value forecast: $ million, 201520
Figure 187: Forces driving competition in the OTC pharmaceuticals market in North America, 2015
Figure 188: Drivers of buyer power in the OTC pharmaceuticals market in North America, 2015
Figure 189: Drivers of supplier power in the OTC pharmaceuticals market in North America, 2015
Figure 190: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in North America, 2015
Figure 191: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in North America, 2015
Figure 192: Drivers of degree of rivalry in the OTC pharmaceuticals market in North America, 2015
Figure 193: Russia OTC pharmaceuticals market value: $ million, 201115
Figure 194: Russia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 195: Russia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 196: Russia OTC pharmaceuticals market share: % share, by value, 2015
Figure 197: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 198: Russia OTC pharmaceuticals market value forecast: $ million, 201520
Figure 199: Forces driving competition in the OTC pharmaceuticals market in Russia, 2015
Figure 200: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2015
Figure 201: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2015
Figure 202: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2015
Figure 203: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2015
Figure 204: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2015
Figure 205: Scandinavia OTC pharmaceuticals market value: $ million, 201115
Figure 206: Scandinavia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 207: Scandinavia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 208: Scandinavia OTC pharmaceuticals market share: % share, by value, 2015
Figure 209: Scandinavia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 210: Scandinavia OTC pharmaceuticals market value forecast: $ million, 201520
Figure 211: Forces driving competition in the OTC pharmaceuticals market in Scandinavia, 2015
Figure 212: Drivers of buyer power in the OTC pharmaceuticals market in Scandinavia, 2015
Figure 213: Drivers of supplier power in the OTC pharmaceuticals market in Scandinavia, 2015
Figure 214: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Scandinavia, 2015
Figure 215: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Scandinavia, 2015
Figure 216: Drivers of degree of rivalry in the OTC pharmaceuticals market in Scandinavia, 2015
Figure 217: Singapore OTC pharmaceuticals market value: $ million, 201115
Figure 218: Singapore OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 219: Singapore OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 220: Singapore OTC pharmaceuticals market share: % share, by value, 2015
Figure 221: Singapore OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 222: Singapore OTC pharmaceuticals market value forecast: $ million, 201520
Figure 223: Forces driving competition in the OTC pharmaceuticals market in Singapore, 2015
Figure 224: Drivers of buyer power in the OTC pharmaceuticals market in Singapore, 2015
Figure 225: Drivers of supplier power in the OTC pharmaceuticals market in Singapore, 2015
Figure 226: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Singapore, 2015
Figure 227: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Singapore, 2015
Figure 228: Drivers of degree of rivalry in the OTC pharmaceuticals market in Singapore, 2015
Figure 229: South Africa OTC pharmaceuticals market value: $ million, 201115
Figure 230: South Africa OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 231: South Africa OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 232: South Africa OTC pharmaceuticals market share: % share, by value, 2015
Figure 233: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 234: South Africa OTC pharmaceuticals market value forecast: $ million, 201520
Figure 235: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2015
Figure 236: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2015
Figure 237: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2015
Figure 238: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2015
Figure 239: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2015
Figure 240: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2015
Figure 241: South Korea OTC pharmaceuticals market value: $ million, 201115
Figure 242: South Korea OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 243: South Korea OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 244: South Korea OTC pharmaceuticals market share: % share, by value, 2015
Figure 245: South Korea OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 246: South Korea OTC pharmaceuticals market value forecast: $ million, 201520
Figure 247: Forces driving competition in the OTC pharmaceuticals market in South Korea, 2015
Figure 248: Drivers of buyer power in the OTC pharmaceuticals market in South Korea, 2015
Figure 249: Drivers of supplier power in the OTC pharmaceuticals market in South Korea, 2015
Figure 250: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Korea, 2015
Figure 251: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Korea, 2015
Figure 252: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Korea, 2015
Figure 253: Spain OTC pharmaceuticals market value: $ million, 201115
Figure 254: Spain OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 255: Spain OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 256: Spain OTC pharmaceuticals market share: % share, by value, 2015
Figure 257: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 258: Spain OTC pharmaceuticals market value forecast: $ million, 201520
Figure 259: Forces driving competition in the OTC pharmaceuticals market in Spain, 2015
Figure 260: Drivers of buyer power in the OTC pharmaceuticals market in Spain, 2015
Figure 261: Drivers of supplier power in the OTC pharmaceuticals market in Spain, 2015
Figure 262: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Spain, 2015
Figure 263: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Spain, 2015
Figure 264: Drivers of degree of rivalry in the OTC pharmaceuticals market in Spain, 2015
Figure 265: Turkey OTC pharmaceuticals market value: $ million, 201115
Figure 266: Turkey OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 267: Turkey OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 268: Turkey OTC pharmaceuticals market share: % share, by value, 2015
Figure 269: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 270: Turkey OTC pharmaceuticals market value forecast: $ million, 201520
Figure 271: Forces driving competition in the OTC pharmaceuticals market in Turkey, 2015
Figure 272: Drivers of buyer power in the OTC pharmaceuticals market in Turkey, 2015
Figure 273: Drivers of supplier power in the OTC pharmaceuticals market in Turkey, 2015
Figure 274: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Turkey, 2015
Figure 275: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Turkey, 2015
Figure 276: Drivers of degree of rivalry in the OTC pharmaceuticals market in Turkey, 2015
Figure 277: United Kingdom OTC pharmaceuticals market value: $ million, 201115
Figure 278: United Kingdom OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 279: United Kingdom OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 280: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
Figure 281: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 282: United Kingdom OTC pharmaceuticals market value forecast: $ million, 201520
Figure 283: Forces driving competition in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 284: Drivers of buyer power in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 285: Drivers of supplier power in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 286: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 287: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 288: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 289: United States OTC pharmaceuticals market value: $ million, 201115
Figure 290: United States OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 291: United States OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 292: United States OTC pharmaceuticals market share: % share, by value, 2015
Figure 293: United States OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 294: United States OTC pharmaceuticals market value forecast: $ million, 201520
Figure 295: Forces driving competition in the OTC pharmaceuticals market in the United States, 2015
Figure 296: Drivers of buyer power in the OTC pharmaceuticals market in the United States, 2015
Figure 297: Drivers of supplier power in the OTC pharmaceuticals market in the United States, 2015
Figure 298: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United States, 2015
Figure 299: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United States, 2015
Figure 300: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United States, 2015
Figure 301: Bayer AG: revenues & profitability
Figure 302: Bayer AG: assets & liabilities
Figure 303: GlaxoSmithKline Plc: revenues & profitability
Figure 304: GlaxoSmithKline Plc: assets & liabilities
Figure 305: Johnson & Johnson: revenues & profitability
Figure 306: Johnson & Johnson: assets & liabilities
Figure 307: Novartis AG: revenues & profitability
Figure 308: Novartis AG: assets & liabilities
Figure 309: The Procter & Gamble Company: revenues & profitability
Figure 310: The Procter & Gamble Company: assets & liabilities
Figure 311: Reckitt Benckiser Group plc: revenues & profitability
Figure 312: Reckitt Benckiser Group plc: assets & liabilities
Figure 313: Sanofi SA: revenues & profitability
Figure 314: Sanofi SA: assets & liabilities
Figure 315: Almirall S.A.: revenues & profitability
Figure 316: Almirall S.A.: assets & liabilities
Figure 317: Pfizer Inc.: revenues & profitability
Figure 318: Pfizer Inc.: assets & liabilities
Figure 319: Suntory Group: revenues & profitability
Figure 320: Suntory Group: assets & liabilities
Figure 321: Abbott Laboratories: revenues & profitability
Figure 322: Abbott Laboratories: assets & liabilities
Figure 323: Cipla Limited: revenues & profitability
Figure 324: Cipla Limited: assets & liabilities
Figure 325: Dabur India Limited: revenues & profitability
Figure 326: Dabur India Limited: assets & liabilities
Figure 327: Darya-Varia Laboratoria Tbk: revenues & profitability
Figure 328: Darya-Varia Laboratoria Tbk: assets & liabilities
Figure 329: PT Kalbe Farma Tbk: revenues & profitability
Figure 330: PT Kalbe Farma Tbk: assets & liabilities
Figure 331: Boehringer Ingelheim GmbH: revenues & profitability
Figure 332: Boehringer Ingelheim GmbH: assets & liabilities
Figure 333: Daiichi Sankyo Co., Ltd.: revenues & profitability
Figure 334: Daiichi Sankyo Co., Ltd.: assets & liabilities
Figure 335: Bristol Myers Squibb Company: revenues & profitability
Figure 336: Bristol Myers Squibb Company: assets & liabilities
Figure 337: Royal DSM N.V.: revenues & profitability
Figure 338: Royal DSM N.V.: assets & liabilities
Figure 339: Pharmstandard OJSC: revenues & profitability
Figure 340: Pharmstandard OJSC: assets & liabilities
Figure 341: Eu Yan Sang International Ltd.: revenues & profitability
Figure 342: Eu Yan Sang International Ltd.: assets & liabilities
Figure 343: Adcock Ingram Holdings Limited: revenues & profitability
Figure 344: Adcock Ingram Holdings Limited: assets & liabilities
Figure 345: Boryung Pharm Co., Ltd.: revenues & profitability
Figure 346: Boryung Pharm Co., Ltd.: assets & liabilities
Figure 347: Whanin Pharmaceutical Co., Ltd.: revenues & profitability
Figure 348: Whanin Pharmaceutical Co., Ltd.: assets & liabilities
Pricing
Discounts available for multiple purchases.